Additive effect of 5-HT2C and CB1 receptor blockade on the regulation of sleep–wake cycle

[1]  M. Wolak,et al.  The inhibitory effect of combination treatment with leptin and cannabinoid CB1 receptor agonist on food intake and body weight gain is mediated by serotonin 1B and 2C receptors. , 2016, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[2]  J. Nobrega,et al.  The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus , 2016, European Neuropsychopharmacology.

[3]  O. Gunduz-Cinar,et al.  Fluoxetine Facilitates Fear Extinction Through Amygdala Endocannabinoids , 2015, Neuropsychopharmacology.

[4]  R. Hampson,et al.  Modulation of food consumption and sleep–wake cycle in mice by the neutral CB1 antagonist ABD459 , 2015, Behavioural pharmacology.

[5]  O. Prospero-Garcia,et al.  2-Arachidonoylglycerol into the lateral hypothalamus improves reduced sleep in adult rats subjected to maternal separation , 2014, Neuroreport.

[6]  R. Maldonado,et al.  Relationships between serotonergic and cannabinoid system in depressive‐like behavior: a PET study with [11C]‐DASB , 2014, Journal of neurochemistry.

[7]  S. Bastianini,et al.  Multiple Sleep Alterations in Mice Lacking Cannabinoid Type 1 Receptors , 2014, PloS one.

[8]  C. Blanco-Centurion,et al.  Endocannabinoid Modulation of Cortical Up-States and NREM Sleep , 2014, PloS one.

[9]  L. Kalmár,et al.  Chronic escitalopram treatment caused dissociative adaptation in serotonin (5-HT) 2C receptor antagonist-induced effects in REM sleep, wake and theta wave activity , 2014, Experimental Brain Research.

[10]  O. Prospero-Garcia,et al.  Endocannabinoids and sleep , 2013, Neuroscience & Biobehavioral Reviews.

[11]  O. Prospero-Garcia,et al.  2-AG into the lateral hypothalamus increases REM sleep and cFos expression in melanin concentrating hormone neurons in rats , 2013, Pharmacology Biochemistry and Behavior.

[12]  Y. Yanagawa,et al.  Electrophysiological and pharmacological properties of GABAergic cells in the dorsal raphe nucleus , 2012, The Journal of Physiological Sciences.

[13]  R. McLaughlin,et al.  Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway , 2012, European Neuropsychopharmacology.

[14]  C. Adori,et al.  Association between the activation of MCH and orexin immunorective neurons and REM sleep architecture during REM rebound after a three day long REM deprivation , 2011, Neurochemistry International.

[15]  S. Umathe,et al.  Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice , 2011, Behavioural Brain Research.

[16]  O. Arias-Carrión,et al.  The emerging role of the endocannabinoid system in the sleep-wake cycle modulation. , 2011, Central nervous system agents in medicinal chemistry.

[17]  J. Monti,et al.  Serotonin control of sleep-wake behavior. , 2011, Sleep medicine reviews.

[18]  J. Monti.  The role of dorsal raphe nucleus serotonergic and non-serotonergic neurons, and of their receptors, in regulating waking and rapid eye movement (REM) sleep. , 2010, Sleep medicine reviews.

[19]  O. Prospero-Garcia,et al.  Oleamide administered into the nucleus accumbens shell regulates feeding behaviour via CB1 and 5-HT2C receptors. , 2010, The international journal of neuropsychopharmacology.

[20]  O. Hassani,et al.  Melanin-concentrating hormone neurons discharge in a reciprocal manner to orexin neurons across the sleep–wake cycle , 2009, Proceedings of the National Academy of Sciences.

[21]  E. Murillo-Rodríguez.  The role of the CB1 receptor in the regulation of sleep , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[22]  R. Tallarida,et al.  Effects of a Cannabinoid1 Receptor Antagonist and Serotonin2C Receptor Agonist Alone and in Combination on Motivation for Palatable Food: A Dose-Addition Analysis Study in Mice , 2008, Journal of Pharmacology and Experimental Therapeutics.

[23]  A. N. van den Pol,et al.  Cannabinoids Excite Hypothalamic Melanin-Concentrating Hormone But Inhibit Hypocretin/Orexin Neurons: Implications for Cannabinoid Actions on Food Intake and Cognitive Arousal , 2007, The Journal of Neuroscience.

[24]  Damien Gervasoni,et al.  Paradoxical (REM) sleep genesis: The switch from an aminergic–cholinergic to a GABAergic–glutamatergic hypothesis , 2006, Journal of Physiology-Paris.

[25]  A. Köfalvi,et al.  CB1 Receptor Antagonism Increases Hippocampal Acetylcholine Release: Site and Mechanism of Action , 2006, Molecular Pharmacology.

[26]  J. Monti,et al.  Effects of activation and blockade of 5-HT2A/2C receptors in the dorsal raphe nucleus on sleep and waking in the rat , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[27]  R. Jakus,et al.  Despite Similar Anxiolytic Potential, the 5-Hydroxytryptamine 2C Receptor Antagonist SB-242084 [6-Chloro-5-methyl-1-[2-(2-methylpyrid-3-yloxy)-pyrid-5-yl Carbamoyl] Indoline] and Chlordiazepoxide Produced Differential Effects on Electroencephalogram Power Spectra , 2005, Journal of Pharmacology and Experimental Therapeutics.

[28]  G. Mengod,et al.  Expression of serotonin 5-HT2C receptors in GABAergic cells of the anterior raphe nuclei , 2005, Journal of Chemical Neuroanatomy.

[29]  R. Jakus,et al.  Increased wakefulness, motor activity and decreased theta activity after blockade of the 5‐HT2B receptor by the subtype‐selective antagonist SB‐215505 , 2004, British journal of pharmacology.

[30]  J. Laitinen,et al.  An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors , 2003, British journal of pharmacology.

[31]  Fang Wang,et al.  The serotonergic system may be involved in the sleep-inducing action of oleamide in rats , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.

[32]  O. Prospero-Garcia,et al.  Potential role of the cannabinoid receptor cb1 in rapid eye movement sleep rebound , 2003, Neuroscience.

[33]  M. Stryker,et al.  Sleep and Sleep Homeostasis in Mice Lacking the 5-HT2c Receptor , 2002, Neuropsychopharmacology.

[34]  T. Freund,et al.  Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers , 2002, Neuropharmacology.

[35]  M. Kano,et al.  Presynaptic Cannabinoid Sensitivity Is a Major Determinant of Depolarization-Induced Retrograde Suppression at Hippocampal Synapses , 2002, The Journal of Neuroscience.

[36]  O. Prospero-Garcia,et al.  Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor , 2001, Neuroreport.

[37]  A. Finazzi-Agro’,et al.  The Activity of Anandamide at Vanilloid VR1 Receptors Requires Facilitated Transport across the Cell Membrane and Is Limited by Intracellular Metabolism* , 2001, The Journal of Biological Chemistry.

[38]  V. Grutta,et al.  m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors , 2001, Neuroscience.

[39]  T. Blackburn,et al.  Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS , 2000, Neuropharmacology.

[40]  D. Julius,et al.  Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide , 1999, Nature.

[41]  A. Sleight,et al.  5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential. , 1998, The Journal of pharmacology and experimental therapeutics.

[42]  R. Harris,et al.  Brain lipids that induce sleep are novel modulators of 5-hydroxytrypamine receptors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[43]  P. Soubrié,et al.  Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis. , 1996, Life sciences.

[44]  J. Monti,et al.  5-HT receptor agonists 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and 8-OH-DPAT increase wakefulness in the rat , 1990 .

[45]  C. Dugovic,et al.  5-HT2 receptors could be primarily involved in the regulation of slow-wave sleep in the rat. , 1987, European journal of pharmacology.

[46]  F. Bloom,et al.  Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle , 1981, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[47]  R. Pertwee.  Endocannabinoids and Their Pharmacological Actions. , 2015, Handbook of experimental pharmacology.

[48]  R. Pertwee,et al.  Pharmacological actions of cannabinoids. , 2005, Handbook of experimental pharmacology.

[49]  J. Leysen,et al.  Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat , 2004, Psychopharmacology.

[50]  K. Sakai,et al.  Unitary characteristics of presumptive cholinergic tegmental neurons during the sleep-waking cycle in freely moving cats , 2004, Experimental Brain Research.

[51]  R. Kirov,et al.  Age-related effect of ritanserin on the sleep-waking phases in rats. , 1998, The International journal of neuroscience.

[52]  R. Kirov,et al.  Age-dependent effect of ketanserin on the sleep-waking phases in rats. , 1998, The International journal of neuroscience.